Patents by Inventor Neta Zuckerman

Neta Zuckerman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250353892
    Abstract: Provided herein are compositions comprising T cells expressing a recombinant virus-specific T cell receptor (rTCR-V) specific for a viral antigen restricted by a predetermined HLA type, rTCR-Vs, methods for preparing them, their use for treatment, and libraries containing such rTCR-V or T cells comprising them.
    Type: Application
    Filed: June 6, 2023
    Publication date: November 20, 2025
    Inventors: Gal CAFRI, Nira VARDA-BLOOM, Elad JACOBY, Amihai LIEBERMAN, Neta ZUCKERMAN, Ayal HENDEL, Nimrod BEN HAIM
  • Publication number: 20250319182
    Abstract: Provided herein are compositions comprising isolated T cells specific for one or more viral antigens derived from viruses such as adenovirus (ADV), cytomegalovirus (CMV), BK virus (BKV), Epstein-Barr virus (EBV), human herpes virus 6 (HHV6), John Cunningham virus (JC), or human immunodeficiency virus (HIV), methods for obtaining them, libraries including them, and uses thereof in treating viral infections.
    Type: Application
    Filed: June 6, 2023
    Publication date: October 16, 2025
    Inventors: Gal CAFRI, Elad JACOBY, Amihai LIEBERMAN, Neta ZUCKERMAN, Nira VARDA-BLOOM
  • Publication number: 20210027857
    Abstract: Gene expression analysis is generally performed on heterogeneous tissue samples consisting of multiple cell types. Current methods developed to separate heterogeneous gene expression rely on prior knowledge of the cell-type composition and/or signatures—these are not available in most public datasets. We present a novel method to identify the cell-type composition, signatures and proportions per sample without need for a priori information. The method was successfully tested on controlled and semi-controlled datasets and performed as accurately as current methods that do require additional information. As such, this method enables the analysis of cell-type specific gene expression using existing large pools of publically available microarray datasets.
    Type: Application
    Filed: July 15, 2020
    Publication date: January 28, 2021
    Inventors: Neta Zuckerman, Yair Noam, Andrea Goldsmith, Peter P. Lee
  • Publication number: 20150072876
    Abstract: Gene expression analysis is generally performed on heterogeneous tissue samples consisting of multiple cell types. Current methods developed to separate heterogeneous gene expression rely on prior knowledge of the cell-type composition and/or signatures—these are not available in most public datasets. We present a novel method to identify the cell-type composition, signatures and proportions per sample without need for a priori information. The method was successfully tested on controlled and semi-controlled datasets and performed as accurately as current methods that do require additional information. As such, this method enables the analysis of cell-type specific gene expression using existing large pools of publically available microarray datasets.
    Type: Application
    Filed: July 21, 2014
    Publication date: March 12, 2015
    Applicant: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Neta Zuckerman, Yair Noam, Andrea Goldsmith, Peter P. Lee